CGEM vs GILD: Which Stock is Better?
Side-by-side comparison of Cullinan Oncology LLC and Gilead Sciences Inc in 2026
CGEM
Cullinan Oncology LLC
—
GILD
Gilead Sciences Inc
$131.27
Key Metrics Comparison
| Metric | CGEM | GILD | Winner |
|---|---|---|---|
| Market Cap | $830.30M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CGEM
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGEM or GILD a better investment?
Comparing CGEM and GILD: Cullinan Oncology LLC has a market cap of $830.30M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGEM and GILD?
CGEM (Cullinan Oncology LLC) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGEM or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGEM or GILD?
Both CGEM and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CGEM or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CGEM or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $830.30M for CGEM.
Should I buy CGEM or GILD in 2026?
Both CGEM and GILD have investment merit. CGEM trades at $N/A while GILD trades at $131.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGEM and GILD stock?
Key differences: Market Cap ($830.30M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CGEM or GILD in 2026?
The choice between CGEM and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CGEM and GILD?
CGEM (Cullinan Oncology LLC) has a market cap of $830.30M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.